A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics (2016)
- Authors:
- USP affiliated authors: GREENE, LEWIS JOEL - FMRP ; CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP ; FAÇA, VITOR MARCEL - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.jprot.2016.05.005
- Subjects: BIOMARCADORES; NEOPLASIAS OVARIANAS; PROTEÍNAS PROTO-ONCOGÊNICAS
- Keywords: Ovarian cancer; Biomarkers; Tumor fluid; Highthroughput proteomics; Multiple reactions monitoring (MRM)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Proteomics
- ISSN: 1874-3919
- Volume/Número/Paginação/Ano: v. 145, p. 226-236, 2016
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
POERSCH, Aline et al. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics. Journal of Proteomics, v. 145, p. 226-236, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jprot.2016.05.005. Acesso em: 19 abr. 2024. -
APA
Poersch, A., Grassi, M. L., Carvalho, V. P. de, Lanfredi, G. P., Palma, C. de S., Greene, L. J., et al. (2016). A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics. Journal of Proteomics, 145, 226-236. doi:10.1016/j.jprot.2016.05.005 -
NLM
Poersch A, Grassi ML, Carvalho VP de, Lanfredi GP, Palma C de S, Greene LJ, Sousa CB, Carrara HHA, Reis FJC dos, Faça VM. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics [Internet]. Journal of Proteomics. 2016 ; 145 226-236.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.jprot.2016.05.005 -
Vancouver
Poersch A, Grassi ML, Carvalho VP de, Lanfredi GP, Palma C de S, Greene LJ, Sousa CB, Carrara HHA, Reis FJC dos, Faça VM. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics [Internet]. Journal of Proteomics. 2016 ; 145 226-236.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.jprot.2016.05.005 - Proteomic analysis of ovarian cancer tumor fluid is a rich source of potential biomarkers
- Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector
- Proteomic analysis of mesenchymal stem cells
- Proteomic analysis of mesenchymal stem cells
- Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital
- A quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein
- Avaliação do tratamento clínico e cirúrgico do fibroadenoma de mama (FA)
- Efeitos da hipofisectomia farmacológica em implantes endometrióticos induzidos experimentalmente em ratas
- DIA is not a new mass spectrometry acquisition method
- Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis
Informações sobre o DOI: 10.1016/j.jprot.2016.05.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
